- C. Fletcher Payne as a consultant to CytomX Therapeutics, Inc.
- Rodney Pearlman, Ph.D. as President and CEO of Incarda Therapeutics, Inc.
- Steffen Helmling, Ph.D. as V.P. Business Development at PolyMedix, Inc.
- Susan Kramer, D.PH placed as V.P. Project & Alliance Management at XOMA (U.S.) LLC
- Bruce Steel placed as Chief Business Officer of Anaphore, Inc.
- Stanford Lee-Yu Peng, M.D./Ph.D. placed as Sr. Director, Medical Affairs at ARYx Therapeutics, Inc.
- Barry Toyonaga, Ph.D. placed as Senior Vice President, Business Development at Traversa Therapeutics, Inc.
- Aaron Kantor, Ph.D. placed as CSO of The Immune Tolerance Institute
- Barry Wolitsky, Ph.D. placed as COO of The Immune Tolerance Network
- Jean Amos Wilson, Ph.D. placed as Sr. Director, Genetic Services at SEQUENOM, Inc.
- Vince Barella placed at Trellis Bioscience as Sr. Director, Finance and Controller.
- Stephen J. Hurst, J.D. placed as Chief Business Officer of the Immune Tolerance Institute, Inc.
- Robert Di Tullio placed as V.P. Regulatory Affairs, Quality and Clinical Affairs of SEQUENOM, Inc.
- Joseph J. Vallner, Ph.D. placed as President & CEO of Capnia, Inc.
- Dan Levitt, M.D., Ph.D. placed as EVP, Research & Development at Cerimon Pharmaceuticals, Inc.
- Christine Meda placed as President of Diamics, Inc.
- Martin Emanuele, Ph.D. placed as Senior Vice President, Business Development at Kemia, Inc.
- Richard Reeves placed as Vice President, Regulatory Affairs & Quality Assurance at Varian Medical Systems, Inc. (Oncology Systems).
- Peter G. Amatulli placed as Vice President of Commercial Development at Gentiae Clinical Research, Inc.
- Alan Lewis, Ph.D. placed as President & CEO of Novocell, Inc.
- Elizabeth Dragon, Ph.D. placed as EVP of Research & Development at SEQUENOM, Inc.
- Maczkov-Biosciences, Inc. assisted in recruiting Robin Allgren, M.D./Ph.D. as a Medical Consultant to Kemia, Inc.
- Xiaoming Zhang placed as Senior Director, Chemistry at Athenagen, Inc.
Inc. assisted in the placement of William F. Daly, Jr. as Senior
Corporate Business Development Director at CHIRON
- Peter A. Fuller, Ph.D. placed as Senior Vice President & Chief Business Officer of Cellular Genomics
Anthony placed as SVP, Business Development at Saegis Pharmaceuticals,
Inc., and David Pritchard placed as Chief Business Officer at RINAT
Placements: Rob Chess from Nektar Therapeutics Joins CoTherix, Inc.
Board, and Jean Jacques Bienaime from Genencor Intl. joins Saegis
- Dale Ando, M.D. placed as V.P. Therapeutic Development & Chief Medical Officer at Sangamo BioSciences
- Bill Rice placed as the President & CEO of Cyternex